FR2705675B1 - Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments. - Google Patents

Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.

Info

Publication number
FR2705675B1
FR2705675B1 FR9306346A FR9306346A FR2705675B1 FR 2705675 B1 FR2705675 B1 FR 2705675B1 FR 9306346 A FR9306346 A FR 9306346A FR 9306346 A FR9306346 A FR 9306346A FR 2705675 B1 FR2705675 B1 FR 2705675B1
Authority
FR
France
Prior art keywords
medicaments
preparation process
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9306346A
Other languages
English (en)
Other versions
FR2705675A1 (fr
Inventor
Guy Marguerite Marie Ge Nadler
Michel Jean Roger Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Laboratoires Pharmaceutiques
Original Assignee
SmithKline Beecham Laboratoires Pharmaceutiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9306346A priority Critical patent/FR2705675B1/fr
Application filed by SmithKline Beecham Laboratoires Pharmaceutiques filed Critical SmithKline Beecham Laboratoires Pharmaceutiques
Priority to JP7500225A priority patent/JPH09501405A/ja
Priority to EP94918377A priority patent/EP0700389A1/fr
Priority to PCT/EP1994/001705 priority patent/WO1994027971A1/fr
Priority to AU69718/94A priority patent/AU6971894A/en
Priority to ZA943641A priority patent/ZA943641B/xx
Priority to TW083104860A priority patent/TW280816B/zh
Publication of FR2705675A1 publication Critical patent/FR2705675A1/fr
Application granted granted Critical
Publication of FR2705675B1 publication Critical patent/FR2705675B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9306346A 1993-05-27 1993-05-27 Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments. Expired - Fee Related FR2705675B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9306346A FR2705675B1 (fr) 1993-05-27 1993-05-27 Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
EP94918377A EP0700389A1 (fr) 1993-05-27 1994-05-24 3-benzazepines ou isoquinolines n-substituees a action antiarythmique
PCT/EP1994/001705 WO1994027971A1 (fr) 1993-05-27 1994-05-24 3-benzazepines ou isoquinolines n-substituees a action antiarythmique
AU69718/94A AU6971894A (en) 1993-05-27 1994-05-24 Anti-arrhythmic n-substituted 3-benzazepines or isoquinolines
JP7500225A JPH09501405A (ja) 1993-05-27 1994-05-24 抗不整脈用ｎ−置換３−ベンズアゼピンまたはイソキノリン
ZA943641A ZA943641B (en) 1993-05-27 1994-05-25 Anit-arrhythmic N-substituted 3-benzazepines or isoquinolines
TW083104860A TW280816B (fr) 1993-05-27 1994-05-28

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9306346A FR2705675B1 (fr) 1993-05-27 1993-05-27 Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.

Publications (2)

Publication Number Publication Date
FR2705675A1 FR2705675A1 (fr) 1994-12-02
FR2705675B1 true FR2705675B1 (fr) 1996-05-03

Family

ID=9447504

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9306346A Expired - Fee Related FR2705675B1 (fr) 1993-05-27 1993-05-27 Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.

Country Status (3)

Country Link
FR (1) FR2705675B1 (fr)
TW (1) TW280816B (fr)
ZA (1) ZA943641B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210317096A1 (en) * 2018-07-20 2021-10-14 Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. Salt of lsd1 inhibitor and a polymorph thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
FR2618149B1 (fr) * 1987-07-16 1989-09-22 Synthelabo Derives de n-aminoalkyl n-phenyl arylamides, leur preparation et leur application en therapeutique
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
ZA943641B (en) 1995-04-12
TW280816B (fr) 1996-07-11
FR2705675A1 (fr) 1994-12-02

Similar Documents

Publication Publication Date Title
FR2707641B1 (fr) Composés de l'imidazol-5-carboxamide, leur procédé de préparation leurs intermédiaires et leur utilisation en thérapeutique.
FR2586683B1 (fr) Nouveaux derives de neothramycine, leur procede de preparation et leur application en tant que medicaments
DZ1869A1 (fr) Nouveaux dérivés de lérythromycine, leur procédé de préparation et leur application comme médicaments.
FR2694290B1 (fr) Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
FR2715843B1 (fr) Compositions cosmétiques antisolaires, procédé de préparation et utilisation.
FR2709754B1 (fr) Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale.
DE3575724D1 (de) Quinolizinon-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3771376D1 (de) Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NL960005I1 (nl) Optisch zuivere verbinding, en werkwijze voor de bereiding daarvan.
NO168654C (no) Fremgangsmaate for polymerisering av 1,3-butadien.
OA06951A (fr) Dérivés de la thiéno-pyridinone, leur procédé de préparation et leur application thérapeutique.
FI874020A0 (fi) Tetrahydrokinolinderivat, foerfarande foer deras framstaellning, deras anvaendning och dessa innehaollande farmaceutiska preparat.
FR2692579B1 (fr) Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2717802B1 (fr) Nouveaux composés aromatiques, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2718441B1 (fr) Nouveaux composés de structure benzisoséléna-zoline et -zine, leur procédé de préparation et leurs applications thérapeutiques.
FR2710065B1 (fr) Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
FR2707986B1 (fr) Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
FR2499081B1 (fr) Derives de 7-oxo-1-azabicyclo (3-2-0) hept-2-ene, leur preparation et leur application en tant que medicaments
FR2636063B1 (fr) Composes phenylpyrroliques utiles en tant que medicaments, leur preparation et leur application
FR2645862B1 (fr) Derives d'isothiazolo-pyrydone azetidinyl substitues, leur preparation et leur application en tant que medicaments
FR2597478B1 (fr) Benzimidazoles et imidazopyridines sulfonamides, leur preparation et leur application en tant que medicaments.
FR2705675B1 (fr) Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
FR2710069B3 (fr) Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
OA08699A (fr) Aminopropionamides substitués, procédé pour leur préparation, produits les contenat et leur utilisation, ainsi que de nouveaux produit intermediaires pour leur préparation.
FR2709753B1 (fr) Nitrates organiques, leur procédé de préparation et leur application comme médicaments.

Legal Events

Date Code Title Description
ST Notification of lapse